IL10 and neoplasm: EBV may also alter the immune response to HPV-transformed cells by producing the viral BCRF1 gene product, an interleukin-10 homolog which modulates the HPV related tumor environment (Meckes et al., 2013; Polz-Dacewicz et al., 2016).